<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04576169</url>
  </required_header>
  <id_info>
    <org_study_id>Tampere University Hospital</org_study_id>
    <nct_id>NCT04576169</nct_id>
  </id_info>
  <brief_title>Trial Comparing Treatment Strategies in Triangular Fibrocartilage Complex Ruptures</brief_title>
  <acronym>REINFORCER</acronym>
  <official_title>tREatment of Triangular FibrOcaRtilage ComplEx Ruptures (REINFORCER): Protocol for Trial Comparing Debridement Versus Diagnostic Arthroscopy in Central or Radial Tears and Physiotherapy Versus Repair in Ulnar Tears</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central Finland Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trial is a prospective, randomized, controlled, outcome assessor and participant (in other&#xD;
      randomization cohort of the trial) blinded, two randomization cohorts, which each has two&#xD;
      parallel 1:1 arms, a multinational and -centre trial comparing the efficacy of 1) debridement&#xD;
      with placebo surgery and 2) repair with physiotherapy. The primary objective is to compare&#xD;
      efficacy of surgery, depending on the type of injury, with either placebo surgery or&#xD;
      physiotherapy in 1-year follow-up in two randomization cohorts.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Triangular fibrocartilage complex (TFCC) injuries are often considered the cause of ulnar&#xD;
      wrist pain. TFCC lesions can be traumatic or degenerative according to classification&#xD;
      suggested by Palmer and Atzei. Primary treatment is conservative, but if symptoms persist,&#xD;
      operative treatment is an option. Depending on the morphology of the tear, the treatment can&#xD;
      be either debridement or repair. Trialists have observed improvement of symptoms after TFCC&#xD;
      repair but all these trials are observational cohorts without proper controls. Efficacy of&#xD;
      surgery has not been studied in randomized controlled trial (RCT) setting.&#xD;
&#xD;
      The investigators planned a prospective, randomized, controlled, outcome assessor and&#xD;
      participant (in other randomization cohort of the trial) blinded, two randomization cohorts,&#xD;
      which each has two parallel 1:1 arms, a multinational and -centre trial comparing the&#xD;
      efficacy of 1) debridement with placebo surgery and 2) repair with physiotherapy.&#xD;
&#xD;
      Institutional Review Board (IRB) of Tampere university hospital has approved the study&#xD;
      protocol. All participants will give written informed consent. The results of the trial will&#xD;
      be disseminated as published articles in peer-reviewed journals.&#xD;
&#xD;
      Outcome measures for different studies are often derived from what clinicians, rather than&#xD;
      patients, thinks to be important. The investigators chose to base the efficacy assessment on&#xD;
      the measure of patient's subjective disability and pain.&#xD;
&#xD;
      There is no clear evidence of the efficacy of the treatments (debridement and repair). It is&#xD;
      justified and ethically correct to compare these treatments to placebo surgery and&#xD;
      physiotherapy. Placebo surgery and physiotherapy are less invasive than debridement and&#xD;
      repair and because of this are even safer to patients than comparable treatments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 27, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Lead investigators (LI), Coordinating research assistant (CRA), operating theatre staff and research assistants (RA) cannot be blinded to the allocation. Outcome assessors are blinded, and they do not participate in the care at any other point of the study than control visits. In the debridement versus placebo surgery randomization cohort all other hospital personnel and participant will be blinded. In repair of the TFCC (1B) versus physiotherapy randomization cohort we will not attempt blinding as the postoperative treatment is different; long immobilization of the physiotherapy group, and on the other hand, early mobilisation of the repair group may have negative impact on the outcomes.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-Rated Wrist Evaluation (PRWE)</measure>
    <time_frame>10 year follow-up, primary time point at 1 year</time_frame>
    <description>PRWE questionnaire is a validated wrist specific questionnaire consisting of 15-item questionnaire about pain and disability in daily living. PRWE gives a value between 0 (best) and 100 (worst). It is specific wrist instrument with good reliability, validity and responsiveness. In this trial we use minimal important difference (MID) value of 8. It is evaluated pre- and postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EQ-5D-3L</measure>
    <time_frame>10 year follow-up</time_frame>
    <description>Health-related quality of life is measured pre- and postoperatively by EQ-5D-3L questionnaire. It is a generic instrument for assessing quality of life comprising five dimensions and VAS for health level. It is validated and widely used in healthcare research.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse and serious adverse events</measure>
    <time_frame>2 year follow-up</time_frame>
    <description>We will record all adverse events: tendon, ligament, nerve or arterial injury; fracture, CRPS, infection, chondral lesion and hematoma or any other condition, which can be attributed to the intervention. We will consider events leading to hospitalisation or death as serious adverse events and these will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient rated global improvement</measure>
    <time_frame>10 year follow-up</time_frame>
    <description>Global improvement is evaluated pre- and postoperatively by the question: &quot;How would you rate the function and pain of your wrist compared to the situation before the treatment?&quot; The options are in 7-step Likert scale from (-3) &quot;Much worse&quot; to (+3) &quot;Much better&quot;. We will dichotomize the response between 0 (not better or worse) +1 (slightly better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain (VAS) in activity</measure>
    <time_frame>10 year follow-up</time_frame>
    <description>VAS in use is assessed pre- and postoperatively by VAS scale. The measurement of wrist pain in the affected hand is measured using a 100-mm horizontal line. Pain score is measured between 0 (mm, no pain) and 100 (mm, worst possible) pain. Higher score means worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>2 year follow-up</time_frame>
    <description>Grip strength is measured pre- and postoperatively with Jamar dynamometer using the handle in 2-position. Elbow is in 90Â° flexion and attached to chest. The result is reported in kilograms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success of blinding with the patient and the outcome assessor</measure>
    <time_frame>1 year follow-up</time_frame>
    <description>At the two-year control it is asked from the patient and the outcome assessor which group they thought to belong treatment or placebo in central or radial tear randomization cohort. The success of blinding will be reported in per cents.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Triangular Fibrocartilage Complex Injury</condition>
  <arm_group>
    <arm_group_label>Central or Radial Tear: Arthroscopic debridement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arthroscopic debridement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Central or Radial Tear: Sham surgery</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Diagnostic arthroscopy only (placebo surgery).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ulnar Tear: Arthroscopic or open repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arthroscopic or open repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ulnar Tear: Physiotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diagnostic arthroscopy and physiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthroscopic Debridement</intervention_name>
    <description>A central or radial TFCC tear found during wrist arthroscopy is debrided with a shaver. Portals are closed with sutures or medical tape. The procedure is performed in general or regional anesthesia in operating room. Immediate mobilization of the wrist is allowed after operation. Instructions of home exercise are handed to the patient and patient is instructed to start the exercises two weeks from the operation.</description>
    <arm_group_label>Central or Radial Tear: Arthroscopic debridement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo surgery</intervention_name>
    <description>Diagnostic arthroscopy only. A central or radial TFCC tear found during wrist arthroscopy is left untouched and no other operative interventions are done. Portals are closed with sutures or medical tape. The procedure is performed in general or regional anesthesia in operating room. Immediate mobilization of the wrist is allowed after operation. Instructions of home exercise are handed to the patient and patient is instructed to start the exercises two weeks from the operation. The procedure is placebo surgery.</description>
    <arm_group_label>Central or Radial Tear: Sham surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthroscopic or Open Repair</intervention_name>
    <description>An ulnar TFCC tear found during wrist arthroscopy is sutured to the capsule or fovea with one of the separately defined methods choosed by the treating hand surgeon. The procedure is performed in general or regional anesthesia in operating room. Wounds are closed and standardized post-operative treatment is started after six weeks.</description>
    <arm_group_label>Ulnar Tear: Arthroscopic or open repair</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Physiotherapy</intervention_name>
    <description>An ulnar TFCC tear found during wrist arthroscopy is left untouched and no other operative interventions are done. Portals are closed with sutures or medical tape. The procedure is performed in general or regional anesthesia in operating room. Physiotherapy exercises of wrist and DRUJ stabilizers is started after two weeks.</description>
    <arm_group_label>Ulnar Tear: Physiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ulnar sided wrist pain&#xD;
&#xD;
          -  age more than 18 years&#xD;
&#xD;
          -  suspicion of TFCC tear in clinical examination (MRI optional)&#xD;
&#xD;
          -  ability to fill the Danish, Finnish, Norwegian or Swedish versions of questionnaires&#xD;
&#xD;
          -  symptom duration more than 3 months, and unsuccessful conservative treatment&#xD;
&#xD;
          -  central, radial or ulnar tear explaining the pain in arthroscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unstable DRUJ which will be defined as &quot;sign of complete instability in clinical&#xD;
             examination&quot;&#xD;
&#xD;
          -  distal TFCC tear in arthroscopy&#xD;
&#xD;
          -  ulnocarpal or DRUJ arthrosis&#xD;
&#xD;
          -  ulnar variance â¥ +2 mm in x-rays&#xD;
&#xD;
          -  age above 65 years&#xD;
&#xD;
          -  rheumatoid arthritis or other inflammatory disease effecting radio- or ulnocarpal or&#xD;
             DRUJ&#xD;
&#xD;
          -  Lunotriquetral instability diagnosed in arthroscopy&#xD;
&#xD;
          -  ECU instability&#xD;
&#xD;
          -  massive tear and degenerated edges or frayed tear which fails suture&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antti Kaivorinne, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mikko P RÃ¤isÃ¤nen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Teemu Karjalainen, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Finland Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aleksi Reito, M.D., Ph.D., Adjunct professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Gvozdenovic, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Copenhagen University Hospital, Gentofte</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan-Ragnar Haugstvedt, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ostfold Hospital Trust</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Wilcke, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ville M Mattila, M.D., Ph.D., Professor</last_name>
    <phone>+3583311611</phone>
    <email>ville.mattila@tuni.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jarkko Jokihaara, M.D., Ph.D., Professor</last_name>
    <phone>+3583311611</phone>
    <email>jarkko.jokihaara@tuni.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Copenhagen University Hospital Gentofte</name>
      <address>
        <city>Copenhagen</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Gvozdenovic, M.D.</last_name>
      <phone>+45 38 67 38 67</phone>
      <email>Robert.Gvozdenovic@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Finland Central Hospital</name>
      <address>
        <city>JyvÃ¤skylÃ¤</city>
        <state>Keski-Suomi</state>
        <zip>40620</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teemu Karjalainen, M.D., Ph.D.</last_name>
      <phone>+358142691811</phone>
      <email>teemu.karjalainen@ksshp.fi</email>
    </contact>
    <contact_backup>
      <last_name>Toni Luokkala, M.D.</last_name>
      <phone>+358142691811</phone>
      <email>toni.luokkala@ksshp.fi</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <state>Pirkanmaa</state>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antti Kaivorinne, M.D.</last_name>
      <phone>+3583311611</phone>
      <email>antti.kaivorinne@pshp.fi</email>
    </contact>
    <contact_backup>
      <last_name>Margit C Karelson, M.D.</last_name>
      <phone>+3583311611</phone>
      <email>margit.karelson@pshp.fi</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <state>Pohjois-Pohjanmaa</state>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johannes Kuorilehto, M.D.</last_name>
      <phone>+35883152011</phone>
      <email>johannes.kuorilehto@psshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <state>Pohjois-Savo</state>
        <zip>70029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Juntunen, M.D.</last_name>
      <phone>+35817173311</phone>
      <email>matti.juntunen@kuh.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Panu Nordback, M.D.</last_name>
      <phone>+35894711</phone>
      <email>panu.nordback@hus.fi</email>
    </contact>
    <contact_backup>
      <last_name>Jorma RyhÃ¤nen, M.D., Ph.D., Adjunct prof.</last_name>
      <phone>+35894711</phone>
      <email>jorma.ryhanen@hus.fi</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <state>Varsinais-Suomi</state>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Markus PÃ¤Ã¤kkÃ¶nen, M.D., Ph.D., Adjunct prof.</last_name>
      <phone>+35823130000</phone>
      <email>markus.paakkonen@tyks.fi</email>
    </contact>
    <contact_backup>
      <last_name>Hanna-Stiina Taskinen, M.D., Ph.D.</last_name>
      <phone>+35823130000</phone>
      <email>hannastiina.taskinen@tyks.fi</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ãstfold Hospital Trust</name>
      <address>
        <city>GrÃ¥lum</city>
        <zip>1714</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan-Ragnar Haugstvedt, M.D., Ph.D.</last_name>
      <phone>+47 69 86 00 00</phone>
      <email>Jan-Ragnar.Haugstvedt@so-hf.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Wilcke, M.D., Ph.D.</last_name>
      <phone>+46 8 517 700 00</phone>
      <email>maria.wilcke@sll.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Finland</country>
    <country>Norway</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 29, 2020</study_first_submitted>
  <study_first_submitted_qc>September 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Jarkko Jokihaara</investigator_full_name>
    <investigator_title>Associate professor of hand surgery</investigator_title>
  </responsible_party>
  <keyword>Arthroscopy</keyword>
  <keyword>Surgery</keyword>
  <keyword>Triangular Fibrocartilage</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Placebo</keyword>
  <keyword>Repair</keyword>
  <keyword>Wrist</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All the IPD will be shared with other researchers by request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data will be available after the publication and it will be available for 15 years.</ipd_time_frame>
    <ipd_access_criteria>By request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

